Eye medication linked to Eye damage and Blindness
Did you know a prescription drug for bladder pain is directly leading to blindness? Elmiron litigation is ongoing with no trial yet in early 2022. In this page, we’ll break down Elmiron’s uses for chronic bladder pain, the current status of Elmiron cases, the lawsuits, and we’ll define some common eye problems and how they differ from Elmiron-specific maculopathy.
Since this is still fresh, there is no Elmiron class action lawsuit yet but there is an Elmiron MDL which we’ll briefly discuss below. Now let’s get into why Janssen Pharmaceuticals (the drug manufacturer) are in hot water over these Elmiron lawsuits and the devastating disabilities affecting thousands of victims.
Dating back to 2019, the journal JAMA Ophthalmology published a case study of 35 patients who used Elmiron for interstitial cystitis with approximately 36% experiencing “dynamic changes in pigmentary abnormalities” with findings suggesting that maculopathy caused by Elmiron and similar drugs is a “vision-threatening condition”.
Since then, more medical literature and studies have come forth showing a link between Elmiron and serious eye disabilities (blindness).
Why is Elmiron prescribed?
Elmiron, also known as pentosan polysulfate sodium PPS, is a prescription medication used to treat bladder pain, bladder pressure, and pelvic issues from interstitial cystitis, a chronic painful bladder syndrome that may also cause frequent urination. Elmiron is the only FDA-approved treatment for this debilitating condition.
